According to the research report titled ‘Global Generic Injectables Market (2022 Edition) - Analysis By Molecule Type, (Small, Large), Therapeutic Area, Container Type, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2022-2027),’ available with MarketStudyReport, global generic injectables market was worth USD 134 billion in 2021 and is reckoned to display immense growth during 2022-2027.

Soaring proportion of elderly population, expiration of branded drug patents, and prevalence of life-threatening diseases are parameters impelling the demand in global generic injectables market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4814124/

Besides, inexpensive nature of generic drugs in comparison to branded ones, and usability in the treatment of major ailments like diabetes, cancer, and others are escalating the progress of the business sphere. 

Moreover, rising approvals of generic injectable drugs is likely to further bolster the expansion of industry.

During the COVID-19 pandemic, a variety of restrictions in terms of travel, border closures, etc. were imposed by governments across the world which severely impacted the demand in hospitals and healthcare services. The disruptions in supply chain disabled the timely drug delivery, and even clinical trials were suspended as researchers were not permitted to visit laboratories which collectively affected the global generic injectables industry trends severely. 

However, in the post-pandemic situation, with the ease of limitations, the drugs whose development was strained can now be patented, which is anticipated to support the business landscape in the forthcoming years. 

Concerning geographical front, Asia Pacific market is poised to generate substantial returns during the assessment timeframe, attributed to rise in adoption of generic drugs particularly due to their cost-effectiveness. Additionally, countries like India and China have observed a high number of chronic diseases which is facilitating the regional market growth. 

Meanwhile, North America market is slated to record significant gains during the stipulated timeframe.

The prominent players in worldwide generic injectables marketplace include Nichi-Iko Pharmaceutical Co. Ltd., Pfizer Inc., Teva Pharmaceuticals Industries Ltd., Novartis International AG, Gland Pharma Limited, Sanofi A/S, Hikma Pharmaceuticals plc, Baxter International Inc., Amneal Pharmaceuticals Private Limited, and Fresenius SE & Co. KGaA among others.